共 50 条
- [3] POST-MARKETING SURVEILLANCE OF APPROVED PHARMACEUTICALS IN THE UNITED-STATES CONTROLLED CLINICAL TRIALS, 1980, 1 (02): : 178 - 178
- [5] Clinical Trial Diversity in Oncology: FDA Takes Action with Post-Marketing Requirements or Commitments ONCOLOGIST, 2022, 27 (12): : 993 - 997
- [9] Post-Marketing Drug Withdrawals: A Review Pharmaceutical Chemistry Journal, 2023, 57 : 1138 - 1146